T2D Research: Effects of medications on night-time blood sugars

UVA Tracking #
HSR210395
Principal Investigator
Rita Basu
Contact
Carlene Alix
Contact Email
Contact Phone
434.243.2855
Official Trial Title
Effects of modulators of gluconeogenesis, glycogenolysis and glucokinase activity on endogenous glucose production in type 2 diabetes
Study Description

The Division of Endocrinology seeks men and women ages 25-80 years with type 2 diabetes for a research study. The purpose of the study is to determine the effects of three different diabetes medications on night-time blood sugars.

Study involves
1. A screening visit including a blood draw, urine test and physical exam
2. 2-4 inpatient visits including 2 overnight visits at the Clinical Research Unit at Fontaine Research Park
3. Treatment for up to 8 weeks with either Metformin, Insulin Glargine which is a long-acting insulin, or the experimental drug Dorzagliatin which is FDA-approved for research.

All visits will be completed within a 3-month period.

Study-related tests and procedures will be provided at no cost.

Contact Email: TeamBasuDiabetes@hscmail.mcc.virginia.edu

Compensation

up to $2500